NZ514058A - Medicament for treating hypertension - Google Patents

Medicament for treating hypertension

Info

Publication number
NZ514058A
NZ514058A NZ514058A NZ51405800A NZ514058A NZ 514058 A NZ514058 A NZ 514058A NZ 514058 A NZ514058 A NZ 514058A NZ 51405800 A NZ51405800 A NZ 51405800A NZ 514058 A NZ514058 A NZ 514058A
Authority
NZ
New Zealand
Prior art keywords
group
benzazepine
oxo
acetic acid
phenylbutyl
Prior art date
Application number
NZ514058A
Other languages
English (en)
Inventor
Martin R Wilkins
Dirk Thormahlen
Harald Waldeck
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NZ514058A publication Critical patent/NZ514058A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ514058A 1999-02-16 2000-02-10 Medicament for treating hypertension NZ514058A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19906310A DE19906310A1 (de) 1999-02-16 1999-02-16 Arzneimittel zur Behandlung von Bluthochdruck

Publications (1)

Publication Number Publication Date
NZ514058A true NZ514058A (en) 2001-09-28

Family

ID=7897580

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ514058A NZ514058A (en) 1999-02-16 2000-02-10 Medicament for treating hypertension

Country Status (28)

Country Link
US (1) US6482820B2 (cg-RX-API-DMAC7.html)
EP (1) EP1154777B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002537258A (cg-RX-API-DMAC7.html)
KR (2) KR100797665B1 (cg-RX-API-DMAC7.html)
CN (1) CN1198619C (cg-RX-API-DMAC7.html)
AR (1) AR036864A1 (cg-RX-API-DMAC7.html)
AT (1) ATE295174T1 (cg-RX-API-DMAC7.html)
AU (1) AU773240C (cg-RX-API-DMAC7.html)
BR (1) BR0008260A (cg-RX-API-DMAC7.html)
CA (1) CA2362273C (cg-RX-API-DMAC7.html)
CZ (1) CZ301499B6 (cg-RX-API-DMAC7.html)
DE (2) DE19906310A1 (cg-RX-API-DMAC7.html)
DZ (1) DZ3014A1 (cg-RX-API-DMAC7.html)
ES (1) ES2238268T3 (cg-RX-API-DMAC7.html)
HK (1) HK1042247B (cg-RX-API-DMAC7.html)
HU (1) HUP0105491A3 (cg-RX-API-DMAC7.html)
IL (1) IL144622A (cg-RX-API-DMAC7.html)
NO (1) NO329588B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ514058A (cg-RX-API-DMAC7.html)
PL (1) PL195283B1 (cg-RX-API-DMAC7.html)
PT (1) PT1154777E (cg-RX-API-DMAC7.html)
RU (1) RU2270679C2 (cg-RX-API-DMAC7.html)
SK (1) SK287254B6 (cg-RX-API-DMAC7.html)
TR (1) TR200102386T2 (cg-RX-API-DMAC7.html)
TW (1) TWI221770B (cg-RX-API-DMAC7.html)
UA (1) UA63032C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000048601A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200105828B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
WO2001036610A1 (en) * 1999-11-19 2001-05-25 Solvay Pharmaceuticals B.V. Human enzymes of the metalloprotease family
IL145684A (en) * 2000-10-04 2007-06-17 Warner Lambert Co Medications for the treatment of pulmonary hypertension
AR039352A1 (es) * 2001-05-18 2005-02-16 Solvay Pharm Gmbh Uso de un compuesto que tiene actividad inhibitoria combinada y concurrente con endopeptidasa neutra y metaloproteasa igs5.
CN100519561C (zh) * 2001-09-10 2009-07-29 泰博特克药品有限公司 制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法
IL162645A0 (en) 2002-01-16 2005-11-20 Solvay Pharm Bv solid salts benzazepine compounds and their use inthe preparation of pharmaceuticals compounds
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US7452875B2 (en) 2003-09-26 2008-11-18 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US7262184B2 (en) 2003-09-26 2007-08-28 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
US7427611B2 (en) 2003-09-26 2008-09-23 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
AR046454A1 (es) * 2003-11-18 2005-12-07 Solvay Pharm Gmbh Uso de un compuesto de acido benzazepin-n-acetico, composicion farmaceutica, y procedimiento para la produccion de dicha composicion farmaceutica
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
US20050267072A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
US7816347B2 (en) 2004-12-15 2010-10-19 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
US20070292503A1 (en) * 2006-06-16 2007-12-20 Gorissen Henricus R Oral pharmaceutical composition of poorly water-soluble active substance
US20070299054A1 (en) * 2006-06-22 2007-12-27 Rajesh Jain Oral pharmaceutical composition of a poorly water-soluble active agent
KR20170005155A (ko) * 2008-01-31 2017-01-11 반더빌트유니버시티 폐의 용태에 따른 치료 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749688A (en) * 1986-06-20 1988-06-07 Schering Corporation Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
EP0254032A3 (en) * 1986-06-20 1990-09-05 Schering Corporation Neutral metalloendopeptidase inhibitors in the treatment of hypertension
CA1337400C (en) * 1987-06-08 1995-10-24 Norma G. Delaney Inhibitors of neutral endopeptidase
US5087702A (en) * 1991-01-30 1992-02-11 Merck & Co., Inc. Microbial transformation process for producing an antihypertensive product
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel

Also Published As

Publication number Publication date
TR200102386T2 (tr) 2002-01-21
DE19906310A1 (de) 2000-08-17
PL195283B1 (pl) 2007-08-31
AU773240C (en) 2004-11-18
CZ20012672A3 (cs) 2002-02-13
BR0008260A (pt) 2001-11-06
HUP0105491A3 (en) 2002-08-28
CZ301499B6 (cs) 2010-03-24
ES2238268T3 (es) 2005-09-01
RU2270679C2 (ru) 2006-02-27
PT1154777E (pt) 2005-07-29
TWI221770B (en) 2004-10-11
NO20013958L (no) 2001-10-15
CA2362273A1 (en) 2000-08-24
SK10822001A3 (sk) 2002-03-05
HK1042247B (zh) 2005-09-23
US20020052361A1 (en) 2002-05-02
DE50010284D1 (de) 2005-06-16
CN1198619C (zh) 2005-04-27
KR20010101922A (ko) 2001-11-15
SK287254B6 (sk) 2010-04-07
ZA200105828B (en) 2002-07-15
UA63032C2 (en) 2004-01-15
IL144622A (en) 2006-08-20
PL350167A1 (en) 2002-11-18
AU773240B2 (en) 2004-05-20
CN1339966A (zh) 2002-03-13
US6482820B2 (en) 2002-11-19
NO20013958D0 (no) 2001-08-15
AR036864A1 (es) 2004-10-13
HK1042247A1 (en) 2002-08-09
CA2362273C (en) 2010-05-25
AU2547600A (en) 2000-09-04
EP1154777A1 (de) 2001-11-21
NO329588B1 (no) 2010-11-15
JP2002537258A (ja) 2002-11-05
WO2000048601A1 (de) 2000-08-24
ATE295174T1 (de) 2005-05-15
EP1154777B1 (de) 2005-05-11
DZ3014A1 (fr) 2004-03-27
HUP0105491A2 (en) 2002-06-29
KR100797665B1 (ko) 2008-01-23
KR20070027719A (ko) 2007-03-09

Similar Documents

Publication Publication Date Title
CA2362273C (en) Benzazepine-n-ethanoic acid derivatives for treating secondary hypertension
US4217347A (en) Method of treating hypertension and medicaments therefor
IE921534A1 (en) Novel composition of angiotensin-ii receptor antagonists and¹calcium channel blockers
US6906059B2 (en) Pharmaceutical composition with protective action against oxidative/toxic substances, especially cardiotoxic substances
JP2002537258A5 (cg-RX-API-DMAC7.html)
EP1687006B1 (en) Pharmaceutical compositions for the treatment of renal dysfunction
MXPA01008164A (en) Medicament for treating hypertension
US3821381A (en) Method of treatment
HK1097762B (en) Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients
JP2000297038A (ja) 医薬組成物
JPH05279253A (ja) 骨粗鬆症予防および治療剤

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed